Form 4 filings across 2 companies. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: +$5M
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
No filings held for this insider can be measured against the deadline.
The 9 most recent Form 4 transactions.
| PBUY |
| 277,778 |
| $18.00 |
| $5M |
| +14.5% |
| Open the original filing on SEC.gov |
| May 1 | AVLN | Avalyn Pharma Inc. | CCONV | 489,486 | — | — | +34.5% | Open the original filing on SEC.gov |
| May 1 | AVLN | Avalyn Pharma Inc. | CCONV | 1.4M | — | — | — | Open the original filing on SEC.gov |
| Apr 28 | ACLX | Arcellx, Inc. | DTOISS◆ | 9,174 | — | — | — | Open the original filing on SEC.gov |
| Apr 28 | ACLX | Arcellx, Inc. | DTOISS◆ | 8,011 | — | — | — | Open the original filing on SEC.gov |
| Apr 28 | ACLX | Arcellx, Inc. | DTOISS◆ | 11,459 | — | — | — | Open the original filing on SEC.gov |
| Apr 28 | ACLX | Arcellx, Inc. | UTENDR | 1.5M | — | — | -100.0% | Open the original filing on SEC.gov |